SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-22-136980
Filing Date
2022-05-02
Accepted
2022-05-02 17:06:43
Documents
3
Group Members
ATLAS MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d352831dsctota.htm SC TO-T/A 49603
2 EX-99.(B)(2) d352831dex99b2.htm EX-99.(B)(2) 147863
3 EX-FILING FEES d352831dexfilingfees.htm EX-FILING FEES 16212
  Complete submission text file 0001193125-22-136980.txt   215817
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-47575 | Film No.: 22883084
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filed by) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2836 Biological Products, (No Diagnostic Substances)